This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Bandana Chakravarti: Innovator in Pharmaceutical Chemistry
Introduction
Bandana Chakravarti, an accomplished inventor based in Lucknow, India, has made significant contributions to the field of pharmaceutical chemistry. With her innovative research and development efforts, she continues to push the boundaries of medical treatment, particularly in oncology.
Latest Patents
Chakravarti holds a notable patent for "Aryl naphthyl methanone oxime(s) and process for preparation thereof." This invention introduces substituted aryl naphthyl methanone oximes that can be utilized in the treatment of various cancers, including chronic myelogenous leukemia, acute myelogenous leukemia, lymphoma, multiple myeloma, and several solid tumors. The implications of her work, particularly in addressing drug-resistant cancer stem cells, make it a vital advancement in cancer research and treatment.
Career Highlights
Currently, Bandana Chakravarti is affiliated with the Council of Scientific and Industrial Research, a prestigious organization dedicated to advancing scientific knowledge in India. Her work at this institution has allowed her to engage in cutting-edge research, furthering her impact in the field of medicinal chemistry.
Collaborations
Throughout her career, Chakravarti has collaborated with esteemed colleagues, including Sabyasachi Sanyal and Atul Kumar. These partnerships have bolstered her research efforts and contributed to the success of her innovations, showcasing her ability to work effectively within a team in a dynamic scientific environment.
Conclusion
Bandana Chakravarti exemplifies the innovative spirit in the realm of pharmaceutical research. Her patented inventions and collaborative efforts highlight her commitment to developing effective treatments for cancer, ultimately aiming to improve patient outcomes and advance the science of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
